Research and Development

Showing 15 posts of 9594 posts found.

Tamiflu image

BMJ blasts Roche for withholding Tamiflu data

January 18, 2012 Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO

Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …

The work of NICE International

January 17, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kalipso Chalkidou, NICE

NICE, or the National Institute for Health and Clinical Excellence, to give it its full title, is world famous for …

CoreLab Partners opens office in Tokyo, Japan

January 17, 2012 Research and Development

Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and …

Oxford BioTherapeutics appoints C. Glenn Begley as a senior clinical advisor

January 17, 2012 Business Services, Research and Development, Sales and Marketing C. Glenn Begley, Oxford Biotherapeutics

Oxford BioTherapeutics has appointed C. Glenn Begley as a senior clinical advisor and non-executive director of the firm.  Dr Begley, …

Contract research news in brief

January 17, 2012 Manufacturing and Production, Research and Development AAIPharma and General Dynamics, Charles River Labs, Covance, ICON, ShangPharma

A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …

Otsuka and UCB scale down collaboration

January 16, 2012 Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB

Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …

AstraZeneca looks for new partners to bolster pipeline

January 16, 2012 Business Services, Research and Development, Sales and Marketing AstraZeneca, BMS

AstraZeneca has used a recent healthcare conference in San Francisco to call for new drug development partners. Speaking at the …

Novartis to cut 2,000 US jobs

January 13, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts

Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …

Pharma unprepared for annus horribilis

January 12, 2012 Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

Merck facility reborn as science park

January 11, 2012 Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …

Crisis in the boardroom: 2011’s most dramatic departures

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management

In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …

Janssen signs deal with rising star Forma

January 11, 2012 Research and Development Forma, Janssen, alliance

Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …

Richard Barker joins Aegate as a senior advisor

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker

Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …
Sanofi picture

Sanofi to collaborate with UCSF on diabetes research

January 11, 2012 Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes

The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …

Underwhelming results for GSK’s Relovair

January 10, 2012 Research and Development, Sales and Marketing Advair, COPD, GSK, Relovair, Seretide, asthma

GlaxoSmithKline says it is on track to file its respiratory drug Relovair in Europe and the US despite mixed results …
The Gateway to Local Adoption Series

Latest content